Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain

Acute d-amphetamine (d-Amph) administration to rats leads to the release of arachiclonic acid (AA, 20:4n-6) as a second messenger following indirect agonism at dopamine D-2-like receptors in the brain. We hypothesized that chronically administered d-Amph in rats also would alter brain AA metabolism and signalling. To test this, adult male rats were injected i.p. daily for 2 wk with saline or 2.5 mg/kg d-Amph. After a 1-d washout, the unanaesthetized rats were injected acutely with i.v. saline, 1 mg/kg quinpirole (a D-2-like receptor agonist) or 5.0 mg/kg SKF-38393 (a D-1-like receptor agonist), followed by i.v. [1-C-14]AA. The AA incorporation coefficient k* (brain radioactivity/integrated plasma radioactivity), a marker of AA signalling and metabolism, was quantified using autoractiography in each of 62 brain regions. Compared with chronic saline, chronic d-Amph widely decreased baseline values of k* in brain regions having D2-like receptors. On the other hand, chronic amphetamine did not alter the k* responses to quinpirole seen in chronic saline-treated rats. SKF-38393 had minimal effects on V in both chronic saline-treated and amphetamine-treated rats, consistent with D-1-like receptors not being coupled to AA signalling. The ability of chronic d-Amph after 1-d washout to down-regulate baseline values of k* probably reflects neuroplastic changes in brain AA signalling, and may correspond to depressive behaviours noted following withdrawal from chronic amphetamine in humans and in rats.